Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Global Licensing Director Stella Xu and Business Development Director Frank Grams On Seeking More Innovation In China And Korea: An Interview With PharmAsia News (Part 2 of 2)

This article was originally published in PharmAsia News

Executive Summary

Roche recently expanded its investment in innovation in Asia by opening its fourth Global Partnering office in Shanghai. Roche Global Licensing Director Stella Xu and Business Development Director Frank Grams sat down with PharmAsia News' Shanghai Bureau to talk about the mission of the newly established partnering site and Roche's partnering strategies in Asia.

You may also be interested in...



Roche Global Head of Business Development & Licensing Joe McCracken On Searching For Innovative Deals In Asia: An Interview With PharmAsia News (Part 1 of 2)

Joe McCracken, global head of business development & licensing for Roche AG, has a unique perspective on dealmaking, filtered through the lens of a career that has spanned from biotech to Big Pharma, from the U.S. West Coast to Japan to Nutley, New Jersey.

Roche Global Head of Business Development & Licensing Joe McCracken On Searching For Innovative Deals In Asia: An Interview With PharmAsia News (Part 1 of 2)

Joe McCracken, global head of business development & licensing for Roche AG, has a unique perspective on dealmaking, filtered through the lens of a career that has spanned from biotech to Big Pharma, from the U.S. West Coast to Japan to Nutley, New Jersey.

Roche Looks To Fuel Early-stage Partnerships In China While Shunning Branded Generics

The Swiss pharma giant also sees more start-ups of interest, particularly ones founded by China returnees who have worked for Western pharmaceutical companies, Roche global BD head says.

Related Content

UsernamePublicRestriction

Register

SC071019

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel